On Tuesday, life sciences company LabCorp announced a new technology platform to help streamline the clinical trial and drug development process.
The platform was designed for LabCorp’s drug development and decentralized clinical trial business, Covance. It hopes to more easily connect patients to trials, decrease administrative tasks, improve trial resiliency and enhance studies through the use...